Literature DB >> 34174997

Improving diversity in research and trial participation: the challenges of language.

Andrew Willis1, Talia Isaacs2, Kamlesh Khunti3.   

Abstract

Year:  2021        PMID： 34174997     DOI： 10.1016/S2468-2667(21)00100-6

Source DB:  PubMed          Journal:  Lancet Public Health


× No keyword cloud information.
  3 in total

1.  Comprehension, utility, and preferences of prostate cancer survivors for visual timelines of patient-reported outcomes co-designed for limited graph literacy: meters and emojis over comics.

Authors:  Lauren E Snyder; Daniel F Phan; Kristen C Williams; Eduardo Piqueiras; Sarah E Connor; Sheba George; Lorna Kwan; Jefersson Villatoro Chavez; Megha D Tandel; Stanley K Frencher; Mark S Litwin; John L Gore; Andrea L Hartzler
Journal:  J Am Med Inform Assoc       Date:  2022-10-07       Impact factor: 7.942

2.  Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP).

Authors:  Ashish Sarraju; Clark Seninger; Vijaya Parameswaran; Christina Petlura; Tamara Bazouzi; Kiranbir Josan; Upinder Grewal; Thomas Viethen; Hardi Mundl; Joachim Luithle; Leonard Basobas; Alexis Touros; Michael J T Senior; Koen De Lombaert; Kenneth W Mahaffey; Mintu P Turakhia; Rajesh Dash
Journal:  NPJ Digit Med       Date:  2022-06-28

3.  Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups-practical guidance to support better practice.

Authors:  Shoba Dawson; Katie Banister; Katie Biggs; Seonaidh Cotton; Declan Devane; Heidi Gardner; Katie Gillies; Gosala Gopalakrishnan; Talia Isaacs; Kamlesh Khunti; Alistair Nichol; Adwoa Parker; Amy M Russell; Victoria Shepherd; Frances Shiely; Gillian Shorter; Bella Starling; Hywel Williams; Andrew Willis; Miles D Witham; Shaun Treweek
Journal:  Trials       Date:  2022-08-17       Impact factor: 2.728
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.